NCT07258004 · NOT YET RECRUITING

An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.

This small study is testing whether people with mild or moderate Alzheimer's disease can realistically drink beetroot juice twice a day for one week. Researchers will track side effects, how acceptable it is, and any changes in health measures. It is a feasibility study with no phase, so it checks practicality, not whether it works.

You may qualify if

  • Aged 65-85 years
  • Mild or Moderate Alzheimer's disease
  • Participants must be able to speak, read, and understand English to participate in this study.
  • To support adherence, participants are asked to have a carer, partner, friend, or family member available to assist with reminders to take the shots twice daily.

You're excluded if

  • Advanced or severe Alzheimer's Disease
  • Diagnosis of an additional neurological condition
  • Have used antibiotics in the last month
  • Use of mouthwash in the last month
  • Use of medication affecting nitrate metabolism (for example proton pump inhibitors, Isosorbide Mononitrate, Sildenafil or Glyceryl Trinitrate).
  • Unable to provide informed consent
  • Allergies to beetroot
  • Taking part in pharmacological trials

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-12-02

View full record on ClinicalTrials.gov

All APOE4 clinical trials